Researchers at Eli Lilly and others published a phase II trial this week that combined semaglutide, the active ingredient in weight loss drugs Ozempic and Wegovy, with bimagrumab, an experimental ...
GI side effects from GLP-1s may cause patients to drop the medications or turn to OTC remedies. Gastroenterologists don’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results